XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities:    
Net income (loss) $ 4 $ (22)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 63 63
Stock-based compensation expense (Note 10) 92 72
Deferred income tax expense (benefit) (24) (8)
Provision for expected credit losses 5 5
Other, net 10 3
Changes in operating assets and liabilities, net:    
Accounts receivable, net, prepaid expenses and other assets (76) (36)
Accounts payable, accrued expenses and other liabilities 42 32
Deferred merchant payables 106 130
Income tax receivables/payables, net (87) (5)
Deferred revenue 12 20
Net cash provided by (used in) operating activities 147 254
Investing activities:    
Capital expenditures, including capitalized website development (51) (47)
Net cash provided by (used in) investing activities (51) (47)
Financing activities:    
Repurchase of common stock (Note 11) (25) (75)
Proceeds from the issuance of Term Loan B Facility, net of financing costs (Note 6) 493 0
Payment of 2025 Senior Notes (Note 6) (500) 0
Payment of financing costs related to Credit Facility (Note 6) (1) (3)
Payment of withholding taxes on net share settlements of equity awards (17) (14)
Payments of finance lease obligation (5) (5)
Net cash provided by (used in) financing activities (55) (97)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 4 (7)
Net increase (decrease) in cash, cash equivalents and restricted cash 45 103
Cash, cash equivalents and restricted cash at beginning of period 1,067 1,021
Cash, cash equivalents and restricted cash at end of period 1,112 1,124
Supplemental disclosure of cash flow information:    
Cash paid (received) during the period for income taxes, net of refunds 195 128
Cash paid during the period for interest $ 48 $ 38